Ishidate K, Nakagomi K, Nakazawa Y
J Biol Chem. 1984 Dec 10;259(23):14706-10.
Choline kinase was purified from rat kidney to apparent homogeneity with respect to both native and sodium dodecyl sulfate-polyacrylamide gel electrophoresis. The purified enzyme showed a minimum molecular weight of 42,000 on sodium dodecyl sulfate-polyacrylamide gel electrophoresis. On the other hand, the molecular size of 75,000-80,000 was estimated through Sephadex G-150 gel filtration, indicating that the enzyme in rat kidney exists most likely in a dimeric form. Specific antibody was raised in rabbit against the highly purified rat kidney choline kinase protein, then immunochemical cross-reactivity was investigated between rabbit antiserum and choline kinase preparations from various rat tissues. The antiserum inhibited choline kinase activity almost completely in the crude preparation not only from kidney but also from lung, intestine, and normal untreated liver cytosol, but it could inhibit only partially the activity from either 3-methylcholanthrene- or carbon tetrachloride-induced rat liver cytosol. The overall results demonstrated that, although choline kinase protein appears to exist in multiple forms in rat tissues, most of them are immunochemically identical, and that either 3-methylcholanthrene- or carbon tetrachloride-inducible form(s) of choline kinase in rat liver could be quite different from a form or forms existing in normal untreated rat liver cytosol.
通过天然聚丙烯酰胺凝胶电泳和十二烷基硫酸钠 - 聚丙烯酰胺凝胶电泳,从大鼠肾脏中纯化胆碱激酶至表观均一性。纯化后的酶在十二烷基硫酸钠 - 聚丙烯酰胺凝胶电泳上显示最小分子量为42,000。另一方面,通过葡聚糖G - 150凝胶过滤估计其分子大小为75,000 - 80,000,这表明大鼠肾脏中的该酶很可能以二聚体形式存在。用高度纯化的大鼠肾脏胆碱激酶蛋白在兔体内制备特异性抗体,然后研究兔抗血清与来自大鼠各种组织的胆碱激酶制剂之间的免疫化学交叉反应性。该抗血清不仅能几乎完全抑制来自肾脏、肺、肠道和未处理正常肝脏细胞质粗提物中的胆碱激酶活性,而且只能部分抑制来自经3 - 甲基胆蒽或四氯化碳诱导的大鼠肝脏细胞质中的胆碱激酶活性。总体结果表明,尽管胆碱激酶蛋白在大鼠组织中似乎以多种形式存在,但它们中的大多数在免疫化学上是相同的,并且大鼠肝脏中经3 - 甲基胆蒽或四氯化碳诱导的胆碱激酶形式可能与未处理正常大鼠肝脏细胞质中存在的一种或多种形式有很大不同。